Research Topics
| L A SzczechSummaryAffiliation: Duke University Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Atrial fibrillation: the beat is faster than the answersLynda A Szczech
Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
Kidney Int 81:432-3. 2012..This Commentary explores gaps in our knowledge of how to treat this vulnerable and sick population...
Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United StatesAlisa M Shea
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, PO Box 17969, Durham, North Carolina, USA
BMC Nephrol 9:5. 2008....
Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapyLynda Anne Szczech
Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
Clin Infect Dis 39:1199-206. 2004..The associations of proteinuria and an elevated creatinine level with progression to acquired immunodeficiency syndrome (AIDS) and death in the era of highly antiretroviral therapy (HAART) have not been fully described...
Microalbuminuria predicts overt proteinuria among patients with HIV infectionL A Szczech
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
HIV Med 11:419-26. 2010..This study examines the association between microalbuminuria and the development of proteinuria among HIV-infected persons...
Associations between CMS's Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis unitsL A Szczech
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA
Kidney Int 69:2094-100. 2006..This suggests that in the contemporary era, interventions in for-profit dialysis units have not impaired their ability to deliver performance benchmarks and do not affect survival...
The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney diseaseLynda Anne Szczech
Department of Medicine, Division of Nephrology, Duke University Medical Center, Durham, NC 27710, USA
Am J Kidney Dis 48:e55-9. 2006....
Research in HIV-related renal diseases lags behind their burden to the 'positive' communityL A Szczech
Duke University Medical Center, Durham, North Carolina 27710, USA
Kidney Int 72:1303-5. 2007..suggests that they remain similar to or worse than outcomes for persons with diabetes mellitus. This study should be used to frame the research resources that we devote to furthering knowledge in this area...
Chronic kidney disease anemia management: what should be done?Lynda Anne Szczech
Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA
Blood Purif 31:186-8. 2011..The renal community now must struggle with how to incentivize quality care and maximize patient quality of life while minimizing the real safety signal of which we are now aware...
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomesLynda A Szczech
Department of Medicine, The Renal Division, Duke University Medical Center, Durham, North Carolina, USA
Kidney Int 74:791-8. 2008..Prospective studies are needed to confirm this relationship and determine safe dosing algorithms for patients unable to achieve target hemoglobin...
Renal disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiationLynda Anne Szczech
Duke University Medical Center, Department of Medicine, Division of Nephrology, Box 3646, Durham, NC 27710, USA
Curr Opin HIV AIDS 4:167-70. 2009..This review will summarize the relevant literature supporting the early initiation of antiretroviral therapy among persons with HIV and kidney disease...
A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatmentLynda A Szczech
Renal Division, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
Kidney Int 77:239-46. 2010..These differential outcomes underscore the need for dedicated trials in these subpopulations...
Acute kidney injury and cardiovascular outcomes in acute severe hypertensionLynda A Szczech
Department of Medicine, Division of Nephrology, Duke University Medical Center, Box 3646, Durham, NC 27710, USA
Circulation 121:2183-91. 2010....
Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study designLynda A Szczech
Renal Division, Department of Medicine, Duke University Medical Center, Durham, NC, USA
Nephrol Dial Transplant 25:2368-75. 2010..Ferric carboxymaltose (FCM) is a novel IV iron formulation designed to permit larger infusions compared to currently available IV standards such as Venofer(R) (iron sucrose)...
Getting the urine to the lab: time to think outside of the specimen cupLynda A Szczech
Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
Kidney Int 79:145-7. 2011..Implications of these associations as well as the mechanisms supporting them are explored...
The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infectionLynda Anne Szczech
Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
Kidney Int 66:1145-52. 2004..This study was undertaken to compare HIVAN to the spectrum of other kidney diseases seen among HIV-infected patients...
Protease inhibitors are associated with a slowed progression of HIV-related renal diseasesL A Szczech
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Clin Nephrol 57:336-41. 2002..This study describes the clinical course of HIV-related renal diseases and the effect of protease inhibitors on their progression...
Key concepts in biostatistics: using statistics to answer the question "is there a difference?"Lynda Anne Szczech
Institute for Renal Outcomes and Health Policy Research, Duke University Medical Center, Durham, North Carolina 27710, USA
Semin Dial 15:347-51. 2002..These concepts are integral to the design and analysis of clinical studies. An understanding of their advantages and applications will enhance the reader's ability to understand and evaluate the literature...
Predictors of proteinuria and renal failure among women with HIV infectionLynda Anne Szczech
Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
Kidney Int 61:195-202. 2002..This study examines the risk factors for proteinuria and renal failure in a large cohort of HIV-infected women not selected for the presence of renal disease...
An introduction to epidemiology and biostatistics and issues in interpretation of studiesLynda Anne Szczech
Institute for Renal Outcomes and Health Policy Research, Duke University Medical Center, Durham, North Carolina 27710, USA
Semin Dial 15:60-5. 2002..This series of articles will help the reader to weigh methods and study designs to understand the appropriate conclusions that may be drawn from any data...
The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysisLynda Anne Szczech
Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
Kidney Int 63:2295-301. 2003..This study describes the clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis to define the clinical needs of this growing population...
Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigationL A Szczech
Duke University Medical Center, Division of Nephrology, Durham, NC 27710, USA
Circulation 105:2253-8. 2002..Although severe chronic kidney disease (CKD) is an independent predictor of mortality among patients with coronary artery disease, the impact of mild CKD on morbidity and mortality has not been fully defined...
Differential survival after coronary revascularization procedures among patients with renal insufficiencyL A Szczech
Division of Nephrology, Department of Medicine, Duke Institute for Renal Outcomes Research and Health Policy, and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
Kidney Int 60:292-9. 2001....
Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and managementL A Szczech
Department of Medicine, Division of Nephrology, Duke University Medical Center, Durham, NC 27710, USA
Clin Infect Dis 33:115-9. 2001..Future research should focus on gaining a better understanding of the distribution and determinants of renal disease among HIV-infected patients as well as on performing controlled studies to test treatment strategies...
Changing hemodialysis thresholds for optimal survivalL A Szczech
Duke Institute for Renal Outcomes Research and Health Policy, Duke University Medical Center, Durham, North Carolina 27710, USA
Kidney Int 59:738-45. 2001..Because of new hemodialysis technologies and evolving demographics of the hemodialysis population, the relationship between the amount of hemodialysis and mortality was examined in contemporary cohorts...
Study designs and their potential influence on conclusionsLynda Anne Szczech
Institute for Renal Outcomes and Health Policy Research, Duke University Medical Center, Durham, North Carolina 27710, USA
Semin Dial 15:207-11. 2002..Through the examination of these methods, the reader will be able to rigorously examine study methods and understand how design affects study conclusions and their application to patient care...
Hypertension and medication-related renal dysfunction in the HIV-infected patientL A Szczech
Duke Institute of Renal Outcomes Research and Health Policy, Duke University Medical Center, Durham, NC 27710, USA
Semin Nephrol 21:386-93. 2001..Knowledge of these interactions and side effects is essential toward caring for the patient with HIV-infection...
Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patientsD N Reddan
Duke Institute of Renal Outcomes Research and Health Policy, Division of Nephrology, Duke University Medical Center, Durham, NC, USA
Am J Kidney Dis 38:57-63. 2001..Patient-related variables (eg, increased prevalence of hypertension and cardiovascular disease) and/or provider-specific factors (eg, timing of surgery in the course of PVD) may be responsible for poorer outcomes...
The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patientsS S Hedayati
Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Kidney Int 69:1662-8. 2006..When used for screening, the threshold for depression should be higher for ESRD compared with non-ESRD patients. Identifying depression using physician interview is important, given the low -LR of self-report scales...
Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patientsJ K Inrig
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27705, USA
Kidney Int 71:454-61. 2007..Further research should attempt to elucidate the mechanisms behind these findings...
Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patientsLynda Anne Szczech
Department of Medicine, Division of Nephrology, Institute for Renal Outcomes Research and Health Policy, Duke University Medical Center, Durham, NC 27705, USA
Nephrol Dial Transplant 18:1585-91. 2003..This analysis characterizes the association between dialysis-related volume expansion and mortality in the context of its interaction with nutritional surrogates...
Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidenceKimberley Evans
Department of Medicine, Division of Nephrology, Duke University Medical Center, Durham, North Carolina 27705, USA
Semin Dial 17:22-9. 2004..Therefore, whether or not nondialytic management alone is appropriate remains a matter of individual judgment that should be decided on a case-by-case basis...
Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM studyMichelle C Odden
Department of Medicine, San FranciscoVeterans Affairs Medical Center 4150 Clement Street, San Francisco, CA 94121, USA
Arch Intern Med 167:2213-9. 2007..Cystatin C measurement may be more sensitive than creatinine for detecting impaired kidney function in persons with HIV...
Microalbuminuria in HIV infectionLynda Anne Szczech
Duke University Medical Center, Department of Medicine, Division of Nephrology, Durham, North Carolina, USA
AIDS 21:1003-9. 2007..Microalbuminuria is associated with increased risk of cardiovascular disease and mortality. The objective of the study was to evaluate if HIV infection was an independent risk factor for microalbuminuria...
Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trialDonal N Reddan
Duke University Medical Center, Box 3646, Durham, NC 27710, USA
J Am Soc Nephrol 16:2162-9. 2005..The atypically low hospitalization and mortality rates for the conventional monitoring group suggest that these findings should be generalized to the US hemodialysis population with caution...
HIV-associated nephropathy: a review of the epidemiology and clinical course in the HAART eraS Susan Hedayati
Department of Medicine, Division of Nephrology, Duke University Medical Center, Durham, North Carolina 27710, USA
AIDS Patient Care STDS 17:57-63. 2003
The evaluation of underlying cardiovascular disease among patients with end-stage renal diseaseS Susan Hedayati
Duke University Medical Center, Department of Medicine, Division of Nephrology, Durham, NC 27710, USA
Adv Chronic Kidney Dis 11:246-53. 2004....
HIV and the kidneys. How to know when something is wrong and why it is importantLynda Anne Szczech
Duke University Medical Center, Durham, North Carolina, USA
Posit Aware 17:32-5. 2006
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery diseaseDonal N Reddan
Duke Institute for Renal Outcomes Research and Health Policy, Division of Nephrology, Duke Clinical Research Institute, Duke University Medical Center, Duke University Medical Center, Durham, North Carolina, USA
J Am Soc Nephrol 14:2373-80. 2003..Among patients with severe CKD, PCI was not associated with improved survival. CABG is associated with greater mortality reduction than PCI in severe CKD...
Renal complications of HIV/AIDSLynda Anne Szczech
BETA 19:27-34. 2007..This article explains how kidney function is assessed, describes the renal complications that are most commonly seen in HIV positive people, and outlines treatment options...
Tenofovir nephrotoxicity: focusing research questions and putting them into clinical contextLynda Anne Szczech
J Infect Dis 197:7-9. 2008
The impact of antiretroviral therapy on HIVANLynda Anne Szczech
Kidney Int 65:1114; author reply 1115. 2004
Definition of proteinuria among women with HIV infectionLynda Anne Szczech
Kidney Int 65:1519. 2004
